Trial Profile
A Randomized, Double-Blind, Placebo-Controlled Pilot Study of the Safety and Therapeutic Activity of ORE1001 in Subjects With Ulcerative Colitis.
Status:
Recruiting
Phase of Trial:
Phase I/II
Latest Information Update: 08 Nov 2021
Price :
$35
*
At a glance
- Drugs GL 1001 (Primary)
- Indications Ulcerative colitis
- Focus Adverse reactions
- 07 Jun 2011 Planned end date changed from Feb 2011 to Jun 2011 as reported by ClinicalTrials.gov.
- 13 Aug 2010 Planned end date changed from 1 Dec 2010 to 1 Feb 2011 as reported by ClinicalTrials.gov.
- 12 Feb 2010 Additional trial location [India], lead trial centres and trial investigators identified as reported by Clinical Trials Registry - India record.